Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of PD-L1/αvβ6 Bispecfic ADC JSKN022
SUZHOU, China, Oct. 24, 2025 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed at Sun Yat-sen University Cancer Center in the phase I clinical study (Study ID: JSKN022-101) of...
HOTELEX Shanghai 2025: Propelling Advancements in Hospitality and Foodservice Amidst the Tourism Surge
SHANGHAI, Jan. 23, 2025 /PRNewswire/ -- The 72/144-hour visa-free transit policy has boosted "China Business & Travel," allowing nationals from 54 countries to travel through 38 ports in 18 provinces visa-free. Visitors can stay up to 72 or 144...